Drug Type Small molecule drug |
Synonyms PF 3049423, PF-3049423, PF3049423 |
Target |
Action inhibitors |
Mechanism PDE5A inhibitors(Phosphodiesterase 5A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ischemic stroke | Phase 2 | United States | 01 Dec 2010 | |
Ischemic stroke | Phase 2 | Bulgaria | 01 Dec 2010 | |
Ischemic stroke | Phase 2 | Canada | 01 Dec 2010 | |
Ischemic stroke | Phase 2 | Czechia | 01 Dec 2010 | |
Ischemic stroke | Phase 2 | France | 01 Dec 2010 | |
Ischemic stroke | Phase 2 | Germany | 01 Dec 2010 | |
Ischemic stroke | Phase 2 | Hungary | 01 Dec 2010 | |
Ischemic stroke | Phase 2 | India | 01 Dec 2010 | |
Ischemic stroke | Phase 2 | Taiwan Province | 01 Dec 2010 |
Phase 2 | 137 | ceppkmgwzx(nihsqzbykt) = kliyzvxvmm kfrsbminbx (zskofevaqe ) | Negative | 01 Mar 2016 | |||
Placebo | ceppkmgwzx(nihsqzbykt) = lbdevptqeu kfrsbminbx (zskofevaqe ) | ||||||
Phase 2 | 181 | (Cohort 1: PF-03049423 1 mg) | duzitphnqu = ogxiccziyr vgbjgrbyjs (hwxsscyzkt, fbejcsneqb - udongstlpi) View more | - | 19 Feb 2016 | ||
placebo+PF-03049423 (Cohort 1: Placebo) | duzitphnqu = xrjwalapcl vgbjgrbyjs (hwxsscyzkt, chlveutewo - cboopiajnb) View more |